In vitro anti-HIV-1 synergy between non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz

被引：0
|
作者：
Kollmann, C
Tremblay, C
Giguel, F
Chou, TC
Hirsch, MS [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Harvard Univ, Program Virol, Boston, MA USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
ANTIVIRAL THERAPY | 2001年 / 6卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：143 / 144
页数：2
相关论文
共 50 条
  • [11] QSAR for non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Duchowicz, Pablo R.
    Fernandez, Michael
    Caballero, Julio
    Castro, Eduardo A.
    Fernandez, Francisco M.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (17) : 5876 - 5889
  • [12] Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1
    Moreno, S
    Casado, JL
    Pérez-Elias, MI
    Dronda, F
    Antela, A
    Moreno, A
    Gutiérrez, C
    AIDS, 2003, 17 (09) : 1413 - 1414
  • [13] Novel theoretically designed HIV-1 non-nucleoside reverse transcriptase inhibitors derived from nevirapine
    Jinfeng Liu
    Xiao He
    John Z. H. Zhang
    Journal of Molecular Modeling, 2014, 20
  • [14] Novel theoretically designed HIV-1 non-nucleoside reverse transcriptase inhibitors derived from nevirapine
    Liu, Jinfeng
    He, Xiao
    Zhang, John Z. H.
    JOURNAL OF MOLECULAR MODELING, 2014, 20 (10)
  • [15] Synthetic Development of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) as Anti-HIV Drugs: Efavirenz and its Derivatives
    Zhang, Jian
    Wang, Yong
    CURRENT ORGANIC CHEMISTRY, 2017, 21 (21) : 2196 - 2206
  • [16] Docking Analysis and Resistance Evaluation of Clinically Relevant Mutations Associated with the HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors Nevirapine, Efavirenz and Etravirine
    Alcaro, Stefano
    Alteri, Claudia
    Artese, Anna
    Ceccherini-Silberstein, Francesca
    Costa, Giosue
    Ortuso, Francesco
    Bertoli, Ada
    Forbici, Federica
    Santoro, Maria Mercedes
    Parrotta, Lucia
    Flandre, Philippe
    Masquelier, Bernard
    Descamps, Diane
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    Perno, Carlo Federico
    Sing, Tobias
    Svicher, Valentina
    CHEMMEDCHEM, 2011, 6 (12) : 2203 - 2213
  • [17] Synthesis and biological evaluation of certain alkenyldiarylmethanes as anti-HIV-1 agents which act as non-nucleoside reverse transcriptase inhibitors
    Cushman, M
    Golebiewski, WM
    Graham, L
    Turpin, JA
    Rice, WG
    FliakasBoltz, V
    Buckheit, RW
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (16) : 3217 - 3227
  • [18] Synthesis and Anti-HIV-1 Evaluation of Some Novel MC-1220 Analogs as Non-Nucleoside Reverse Transcriptase Inhibitors
    Loksha, Yasser M.
    Pedersen, Erik B.
    Loddo, Roberta
    La Colla, Paolo
    ARCHIV DER PHARMAZIE, 2016, 349 (05) : 363 - 372
  • [19] Mechanisms of resistance of HIV-1 reverse transcriptase to nucleoside and non-nucleoside inhibitors
    Boyer, PL
    Tantillo, C
    Ding, J
    Ferris, AL
    Clark, P
    Arnold, E
    Hughes, SH
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 6 - 6
  • [20] Discovery of triazolinone non-nucleoside inhibitors of HIV reverse transcriptase
    Sweeney, Zachary K.
    Acharya, Sahaja
    Briggs, Andrew
    Dunn, James P.
    Elworthy, Todd R.
    Fretland, Jennifer
    Giannetti, Anthony M.
    Heilek, Gabrielle
    Li, Yu
    Kaiser, Ann C.
    Martin, Michael
    Saito, Y. David
    Smith, Mark
    Suh, Judy M.
    Swallow, Steven
    Wu, Jeffrey
    Hang, Julie Q.
    Zhou, Amy S.
    Klumpp, Klaus
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (15) : 4348 - 4351
12345